
    
      Evaluation of the safety and the efficacy of a combination of oxaliplatin and 5FU (Folfox) in
      patients with ovarian carcinoma relapsing either after platinum-combined regimen.

      The Folfox regimen is administered every 14 days. Evaluation of the toxicity is performed at
      each cycle and evaluation of the efficacy every 4 cycles of chemotherapy.
    
  